Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.3, 2008-01, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Meropenem in Patients with Renal Failure and Patients Receiving Renal Replacement Therapy

By Thalhammer F.

Clinical Pharmacokinetics, Vol. 39, Iss. 4, 2000-10 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

Biomarkers upon discontinuation of renal replacement therapy predict 60‐day survival and renal recovery in critically ill patients with acute kidney injury

Hemodialysis International, Vol. 22, Iss. 1, 2018-01 ,pp. : 56-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic Evaluation of Meropenem and Imipenem in Critically Ill Patients with Sepsis

By Novelli Andrea

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 539-549

Adis International

Access to resources Recommend Favorite

Plasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 5-12

Bentham Science Publishers

Access to resources Recommend Favorite

Continuous Infusion of Antibiotics in Critically Ill Patients

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 13-24

Bentham Science Publishers

Access to resources Recommend Favorite